BioNTech SE (ETR:22UA)
Germany · Delayed Price · Currency is EUR 89.05
+1.20 (1.37%)
At close: Nov 28, 2025
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of €21.39 billion as of November 28, 2025. Its market cap has decreased by -10.96% in one year.
Market Cap
21.39B
Enterprise Value
6.94B
Revenue
3.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
€89.05
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from 2.72B to 21.39B, an increase of 686.21%. That is a compound annual growth rate of 39.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 21.39B | -18.94% |
| Dec 31, 2024 | 26.39B | 16.25% |
| Dec 29, 2023 | 22.70B | -33.55% |
| Dec 30, 2022 | 34.16B | -37.61% |
| Dec 31, 2021 | 54.75B | 241.19% |
| Dec 31, 2020 | 16.05B | 134.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.43B |
| Siemens Healthineers AG | 47.80B |
| Bayer Aktiengesellschaft | 29.95B |
| Fresenius SE & Co. KGaA | 26.66B |
| Sartorius Aktiengesellschaft | 15.41B |
| Fresenius Medical Care AG | 11.88B |
| Carl Zeiss Meditec AG | 3.90B |
| Fielmann Group AG | 3.68B |